版本:
中国

BRIEF-Five Prime Therapeutics Q1 loss per share $1.21

May 4 Five Prime Therapeutics Inc

* Five Prime announces first quarter 2017 results and provides business update

* Q1 loss per share $1.21

* Q1 earnings per share view $-1.03 -- Thomson Reuters I/B/E/S

* Five Prime Therapeutics - company estimates ending 2017 with approximately $300 million in cash, cash equivalents and marketable securities Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐